Drug factory · FDA FEI 3008759559
Eurofins BioPharma Product Testing Sweden AB
Virdings Allé 2, Uppsala, Sweden
Problems found, fixed voluntarily at FDA's last inspection, Jun 19, 2024.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
2 drug inspections on record since 2019: 1 with no problems, 1 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Remimazolam | Tests it | Acacia Pharma, Ltd. | 71390-011 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Jun 19, 2024 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Jun 27, 2019 | No problems found | Drug Quality Assurance | — |
Registered with FDA for: analysis.